Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:LUNG NASDAQ:NXGL NASDAQ:TELA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$1.97-4.4%$2.11$0.76▼$2.73$77.91M1.4362,060 shs30,514 shsLUNGPulmonx$1.61-4.7%$2.19$1.47▼$9.37$68.86M0.43605,573 shs269,735 shsNXGLNexGel$2.29-2.1%$2.45$2.10▼$5.10$18.88M0.5849,427 shs48,246 shsTELATELA Bio$1.57-1.9%$1.82$0.86▼$3.26$63.39M0.8484,401 shs83,718 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%+7.29%-5.50%+17.05%+64.80%LUNGPulmonx-0.59%-2.31%+9.03%-48.16%-76.23%NXGLNexGel+5.41%-0.43%-13.01%-2.09%-14.91%TELATELA Bio-1.23%-8.05%-6.98%-14.44%-41.61%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$1.97-4.4%$2.11$0.76▼$2.73$77.91M1.4362,060 shs30,514 shsLUNGPulmonx$1.61-4.7%$2.19$1.47▼$9.37$68.86M0.43605,573 shs269,735 shsNXGLNexGel$2.29-2.1%$2.45$2.10▼$5.10$18.88M0.5849,427 shs48,246 shsTELATELA Bio$1.57-1.9%$1.82$0.86▼$3.26$63.39M0.8484,401 shs83,718 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%+7.29%-5.50%+17.05%+64.80%LUNGPulmonx-0.59%-2.31%+9.03%-48.16%-76.23%NXGLNexGel+5.41%-0.43%-13.01%-2.09%-14.91%TELATELA Bio-1.23%-8.05%-6.98%-14.44%-41.61%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate BuyN/AN/ALUNGPulmonx 2.56Moderate Buy$7.66376.04% UpsideNXGLNexGel 0.00N/AN/AN/ATELATELA Bio 2.50Moderate Buy$4.50186.62% UpsideCurrent Analyst Ratings BreakdownLatest NXGL, APYX, LUNG, and TELA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$16.008/1/2025LUNGPulmonxWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$6.00 ➝ $3.007/31/2025LUNGPulmonxLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $8.007/31/2025LUNGPulmonxStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$16.00 ➝ $5.007/31/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$17.00 ➝ $16.007/31/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$9.00 ➝ $2.50(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$46.51M1.60N/AN/A$0.38 per share5.18LUNGPulmonx$90.55M0.72N/AN/A$2.17 per share0.74NXGLNexGel$8.69M2.13N/AN/A$0.90 per share2.54TELATELA Bio$75.32M0.83N/AN/A$0.72 per share2.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%11/7/2025 (Estimated)LUNGPulmonx-$56.39M-$1.43N/AN/AN/A-62.88%-69.76%-36.26%10/29/2025 (Estimated)NXGLNexGel-$3.28M-$0.40N/A∞N/A-25.02%-49.37%-25.68%11/12/2025 (Estimated)TELATELA Bio-$37.84M-$1.12N/AN/AN/A-54.12%-329.48%-57.34%11/6/2025 (Estimated)Latest NXGL, APYX, LUNG, and TELA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025NXGLNexGel-$0.07-$0.09-$0.02-$0.09$3.08 million$2.88 million8/11/2025Q2 2025TELATELA Bio-$0.18-$0.22-$0.04-$0.22$20.67 million$20.20 million8/7/2025Q2 2025APYXApyx Medical-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 million7/30/2025Q2 2025LUNGPulmonx-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/ANXGLNexGelN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical4.614.723.95LUNGPulmonx0.545.354.63NXGLNexGel0.161.740.98TELATELA Bio4.143.192.59Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%LUNGPulmonx91.04%NXGLNexGel2.21%TELATELA Bio94.35%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%LUNGPulmonx6.80%NXGLNexGel20.55%TELATELA Bio4.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.82 million32.07 millionOptionableLUNGPulmonx25040.75 million37.98 millionOptionableNXGLNexGel108.07 million6.41 millionNot OptionableTELATELA Bio12039.62 million37.75 millionOptionableNXGL, APYX, LUNG, and TELA HeadlinesRecent News About These Companies200,000 Shares in TELA Bio, Inc. $TELA Acquired by Paradigm Capital Management Inc. NYSeptember 2, 2025 | marketbeat.com747,410 Shares in TELA Bio, Inc. $TELA Acquired by Velan Capital Investment Management LPAugust 31, 2025 | marketbeat.comStonepine Capital Management LLC Has $2.51 Million Stake in TELA Bio, Inc. $TELAAugust 26, 2025 | marketbeat.comTELA Bio (NASDAQ:TELA) Shares Down 2.9% - Here's What HappenedAugust 23, 2025 | marketbeat.comAroa Biosurgery Reports Strong Growth and Expands Product Range Amid Market ChallengesAugust 20, 2025 | msn.comTela Bio reports Q2 EPS (22c), consensus (19c)August 13, 2025 | msn.comTELA Bio (NASDAQ:TELA) Issues Earnings ResultsAugust 12, 2025 | marketbeat.comTela Bio backs FY25 revenue view $85M-$88M, consensus $86.05MAugust 12, 2025 | msn.comTela Bio reiterates $85M–$88M 2025 revenue target as international expansion acceleratesAugust 12, 2025 | msn.comTELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue EstimatesAugust 11, 2025 | zacks.comTELA Bio, Inc. (TELA) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comTELA Bio Reports Second Quarter 2025 Financial ResultsAugust 11, 2025 | globenewswire.comTELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To ExpectAugust 10, 2025 | finance.yahoo.comTELA Bio Awards Inducement Equity Grants to New EmployeesAugust 10, 2025 | msn.comTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 | globenewswire.comTELA Bio to Participate in the Canaccord Genuity 45th Annual Growth ConferenceJuly 23, 2025 | globenewswire.comTELA Bio to Announce Second Quarter 2025 Financial ResultsJuly 21, 2025 | globenewswire.comTELA Bio, Inc. (TELA) Latest Stock News & Headlines - Yahoo FinanceJuly 19, 2025 | finance.yahoo.comBreakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA)July 3, 2025 | finance.yahoo.comTELA Bio Welcomes Jim Hagen with Strategic Equity GrantJune 9, 2025 | msn.comTELA Bio, Inc.: TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)June 7, 2025 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is ExpectedBy Thomas Hughes | September 4, 2025NXGL, APYX, LUNG, and TELA Company DescriptionsApyx Medical NASDAQ:APYX$1.97 -0.09 (-4.37%) Closing price 04:00 PM EasternExtended Trading$2.00 +0.03 (+1.78%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Pulmonx NASDAQ:LUNG$1.61 -0.08 (-4.73%) Closing price 04:00 PM EasternExtended Trading$1.62 +0.01 (+0.93%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.NexGel NASDAQ:NXGL$2.29 -0.05 (-2.14%) Closing price 03:59 PM EasternExtended Trading$2.29 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.TELA Bio NASDAQ:TELA$1.57 -0.03 (-1.88%) Closing price 04:00 PM EasternExtended Trading$1.56 -0.01 (-0.32%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Despite Pullback, Rocket Lab Still Looks Primed for a Breakout Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
